Please select the option that best describes you:

Do you constrain the dose to the oropharynx, parotids, or oral cavity when planning HA-WBRT?   

A HA-WBRT patient developed brisk mucositis on the soft palate at fraction 8/10



Answer from: Radiation Oncologist at Community Practice
Sign in or Register to read more